SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge📊Experiments🤖Agents🚦Status📑Docs
Info
ℹVision⭐Showcase📽Demo
📖

Nigral Microglia in Progressive Supranuclear Palsy

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-nigral-microglia-psp
Related Entities
cell-types-nigral-microglia-psp
Metadata
slugcell-types-nigral-microglia-psp
entity_typecell
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (136)
mentions🧪Netrin-1 Gradient Restoration100%
mentions🧪Complement C1q Subtype Switching100%
mentions🧪Microglial Purinergic Reprogramming100%
mentions🧪Sphingolipid Metabolism Reprogramming100%
mentions🧪Glial Glycocalyx Remodeling Therapy100%
mentions🧪Aquaporin-4 Polarization Rescue100%
mentions🧪Ephrin-B2/EphB4 Axis Manipulation100%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
related🧫Brainstem Circuit Modulation for PSP70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫PSP and CBS Biomarker Validation Study70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
related🧫4R-Tau Targeting Therapies for PSP and CBS70%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
related🧫Brainstem Circuit Modulation for PSP70%
related🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre70%
related🧫PSP and CBS Biomarker Validation Study70%
related🧫Tau Pathology Initiation Zone Identification70%
related🧫Tau Spreading Network Mapping via Spatial Transcriptomics in70%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp60%
mentions🔬PSP and CBD both involve 4R-tau but produce distinct neuropa60%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
related🧫Progranulin Replacement Therapy for FTD — Vector Development60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
see_also📖Genes60%
see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%
see_also📖Frontotemporal Dementia (FTD)60%
see_also📖Apoptosis in Neurodegeneration60%
see_also📖cdkn2a60%
see_also📖DUSP10 Gene60%
see_also📖Alzheimer Indonesia60%
see_also📖Dementia Australia60%
see_also📖diseases-amyotrophic-lateral-sclerosis60%
see_also📖Packard Center for ALS Research60%
see_also📖Autophagy Enhancement Drug Screening for Neurodegeneration60%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp54%
related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa54%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
mentions🧫4R-Tau Targeting Therapies for PSP and CBS50%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri50%
mentions🧫Brainstem Circuit Modulation for PSP50%
mentions🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre50%
mentions🧫PSP and CBS Biomarker Validation Study50%
mentions🧫Tau Pathology Initiation Zone Identification50%
mentions🧫Tau Spreading Network Mapping via Spatial Transcriptomics in50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪Senescent Cell Mitochondrial DNA Release50%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🧪Orexin-Microglia Modulation Therapy50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬Analyze the spectrum of microglial activation states (DAM, h50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea50%
related🔬Senolytics targeting p16/p21+ senescent astrocytes and micro50%
related🔬Synaptic pruning by microglia in early AD50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
mentions🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%
mentions🔬What are the mechanisms underlying synaptic pruning by micro40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h40%
mentions🔬Senolytics targeting p16/p21+ senescent astrocytes and micro40%
mentions🔬Synaptic pruning by microglia in early AD40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
related🧪Orexin-Microglia Modulation Therapy40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi35%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia35%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro35%
related🔬What are the mechanisms underlying selective vulnerability o30%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub